Open Access Research Article Article ID: JAMTS-2-111

    Fast Treatment of Methamphetamine Related Anxiety and Depressive Disorders: A Novel Approach

    Jamshid Ahmadi*

    Background: Methamphetamine abuse and dependence is currently a considerable problem.

    Objective: To explain the efficacy of buprenorphine in the quick management of methamphetamine related anxiety and depressive disorders and also methamphetamine withdrawal craving.

    Results: 52 mg of buprenorphine is very valuable in the treatment of severe methamphetamine related anxiety and depression and also methamphetamine craving.

    Discussion: This study lightens that high dose of buprenorphine is quite effective in the lowering of anxiety, depression, and chest pain and methamphetamine withdrawal symptoms. Hence, our finding is a substantial addition to the literature.

    Conclusions: We resulted that a single high dose of buprenorphine could quickly subside methamphetamine induced anxiety, depression, psychogenic pain and withdrawal symptoms. It looks that buprenorphine may be a safe and valuable drug for the treatment of the majority of methamphetamine associated disorders.

    Keywords: Methamphetamine related disorders; Buprenorphine; Single dose

    Published on: Mar 8, 2016 Pages: 1-3

    Full Text PDF Full Text HTML DOI: 10.17352/2455-3484.000011
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on JAMTS